About our brands: Cellartis
Our Cellartis brand encompasses over 15 years of experience providing products and services for research applications involving stem cells. The brand originates from a company of the same name (now Takara Bio Europe AB), which was formed by researchers from the University of Gothenburg in 2001.
Historically, a primary focus of the Cellartis brand involved developing and distributing stem cell lines—including both human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs)—for general or custom applications. More recently, the scope of the brand has expanded to also include products such as culture systems, media, and reagents, which make our expertise and innovative technologies more readily accessible to life sciences researchers. An important milestone for the brand involved the development and commercialization of the Cellartis DEF-CS Culture System, a revolutionary approach to culturing stem cells that offers significant advantages relative to other methods.
For the future, a point of emphasis for the Cellartis brand will be the development of products and services targeted at specific research applications involving hiPSCs. One recent example of this is the Cellartis iPS Cell to Hepatocyte Differentiation System, which enables researchers to easily generate hepatocytes from iPSCs on demand, for applications such as drug development.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2020 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.